Artemis Medicare Services Limited (NSE:ARTEMISMED)
India · Delayed Price · Currency is INR | Market Cap | 43.85B +29.2% |
| Revenue (ttm) | 10.81B +15.4% |
| Net Income | 1.04B +25.4% |
| EPS | 6.56 +23.5% |
| Shares Out | 158.31M |
| PE Ratio | 42.23 |
| Forward PE | 32.72 |
| Dividend | 0.45 (0.16%) |
| Ex-Dividend Date | Jul 10, 2026 |
| Volume | 325,468 |
| Open | 275.00 |
| Previous Close | 277.00 |
| Day's Range | 272.95 - 277.00 |
| 52-Week Range | 203.35 - 297.50 |
| Beta | 0.27 |
| Analysts | Buy |
| Price Target | 335.00 (+22.64%) |
| Earnings Date | Aug 7, 2026 |
About Artemis Medicare Services
Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, and inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well... [Read more]
Financial Performance
In fiscal year 2026, Artemis Medicare Services's revenue was 10.81 billion, an increase of 15.40% compared to the previous year's 9.37 billion. Earnings were 1.04 billion, an increase of 25.41%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for ARTEMISMED stock is "Buy." The 12-month stock price target is ₹335.00, which is an increase of 22.64% from the latest price.
News
Artemis Medicare Services announces closure of cardiac centre in Chennai
Artemis Medicare Services Limited has announced the closure of one of its cardiac centres located in Chennai, effective from January 23, 2025. This decision was made today, January 15, 2025, and is pa...